Genetic control of anticoagulation

This publication has 8 references indexed in Scilit:

• Multicentre randomised study of computerised anticoagulant dosage
  The Lancet, 1998
• Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
  The Lancet, 1998
• Missense mutations at ALA‐10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy
  British Journal of Haematology, 1997
• A mutation in the propeptide of Factor IX leads to warfarin sensitivity by a novel mechanism.
  Journal of Clinical Investigation, 1996
• Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)
  The Lancet, 1996
• Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
  The Lancet, 1994
• Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
  The American Journal of Medicine, 1993
• Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery.
  BMJ, 1987